{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T04:34:48Z","timestamp":1722054888070},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T00:00:00Z","timestamp":1447286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T00:00:00Z","timestamp":1447286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/gene.2015.48","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T14:05:09Z","timestamp":1447337109000},"page":"30-45","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo"],"prefix":"10.1038","volume":"17","author":[{"given":"R","family":"Dey-Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A A","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,12]]},"reference":[{"key":"BFgene201548_CR1","first-page":"69","volume":"146","author":"RE Boissy","year":"2011","unstructured":"Boissy RE, Nordlund JJ . Vitiligo: current medical and scientific understanding. G Ital Dermatol Venereol 2011; 146: 69\u201375.","journal-title":"G Ital Dermatol Venereol"},{"key":"BFgene201548_CR2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0738-081X(97)00128-4","volume":"15","author":"JJ Nordlund","year":"1997","unstructured":"Nordlund JJ . The epidemiology and genetics of vitiligo. Clin Dermatol 1997; 15: 875\u2013878.","journal-title":"Clin Dermatol"},{"key":"BFgene201548_CR3","first-page":"pp 616","volume-title":"Fitzpatrick's Dermatol General Medicine","author":"K Wolff","year":"2007","unstructured":"Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ . Fitzpatrick's Dermatol General Medicine, 7th edn, vol. 1. Mac Graw Hill: New York, NY, USA, 2007: pp 616\u2013621."},{"key":"BFgene201548_CR4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0738-081X(97)00130-2","volume":"15","author":"SK Hann","year":"1997","unstructured":"Hann SK, Park YK, Chun WH . Clinical features of vitiligo. Clin Dermatol 1997; 15: 891\u2013897.","journal-title":"Clin Dermatol"},{"key":"BFgene201548_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/jid.1959.49","volume":"32","author":"AB Lerner","year":"1959","unstructured":"Lerner AB . Vitiligo. J Invest Dermatol 1959; 32: 285\u2013310.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0163-8343(79)90081-1","volume":"1","author":"J Porter","year":"1979","unstructured":"Porter J, Beuf AH, Nordlund JJ, Lerner AB . Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry 1979; 1: 73\u201377.","journal-title":"Gen Hosp Psychiatry"},{"key":"BFgene201548_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2005.01369.x","volume":"20","author":"K Ongenae","year":"2006","unstructured":"Ongenae K, Beelaert L, van Geel N, Naeyaert JM . Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 1\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFgene201548_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0190-9622(90)70028-G","volume":"22","author":"JR Porter","year":"1990","unstructured":"Porter JR, Beuf AH, Lerner AB, Nordlund JJ . The effect of vitiligo on sexual relationships. J Am Acad Dermatol 1990; 22: 221\u2013222.","journal-title":"J Am Acad Dermatol"},{"key":"BFgene201548_CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jamadermatol.2013.927","volume":"149","author":"JI Silverberg","year":"2013","unstructured":"Silverberg JI, Silverberg NB . Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol 2013; 149: 159\u2013164.","journal-title":"JAMA Dermatol"},{"key":"BFgene201548_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0625.2007.00666_1.x","volume":"17","author":"KU Schallreuter","year":"2008","unstructured":"Schallreuter KU, Bahadoran P, Picardo M, Slominski A, Elassiuty YE, Kemp EH et al. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol 2008; 17: 139\u2013140; discussion 141-60.","journal-title":"Exp Dermatol"},{"key":"BFgene201548_CR11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1590\/abd1806-4841.20142573","volume":"89","author":"RG Tarle","year":"2014","unstructured":"Tarle RG, Nascimento LM, Mira MT, Castro CC . Vitiligo\u2014part 1. An Bras Dermatol 2014; 89: 461\u2013470.","journal-title":"An Bras Dermatol"},{"key":"BFgene201548_CR12","doi-asserted-by":"crossref","first-page":"984","DOI":"10.7196\/SAMJ.7046","volume":"103","author":"P Manga","year":"2013","unstructured":"Manga P, Kerr R, Ramsay M, Kromberg JG . Biology and genetics of oculocutaneous albinism and vitiligo\u2014common pigmentation disorders in southern Africa. S Afr Med J 2013; 103: 984\u2013988.","journal-title":"S Afr Med J"},{"key":"BFgene201548_CR13","first-page":"35","volume":"24","author":"P Mahdi","year":"2012","unstructured":"Mahdi P, Rouzbahani M, Amali A, Rezaii Khiabanlu S, Kamali M . Audiological manifestations in vitiligo patients. Iran J Otorhinolaryngol 2012; 24: 35\u201340.","journal-title":"Iran J Otorhinolaryngol"},{"key":"BFgene201548_CR14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1468-3083.2006.01655.x","volume":"20","author":"E Bulbul Baskan","year":"2006","unstructured":"Bulbul Baskan E, Baykara M, Ercan I, Tunali S, Yucel A . Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol 2006; 20: 829\u2013833.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFgene201548_CR15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","volume":"21","author":"N Rezaei","year":"2007","unstructured":"Rezaei N, Gavalas NG, Weetman AP, Kemp EH . Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol 2007; 21: 865\u2013876.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFgene201548_CR16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","volume":"16","author":"K Ongenae","year":"2003","unstructured":"Ongenae K, Van Geel N, Naeyaert JM . Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003; 16: 90\u2013100.","journal-title":"Pigment Cell Res"},{"key":"BFgene201548_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0749.1994.tb00013.x","volume":"7","author":"MB Abdel-Naser","year":"1994","unstructured":"Abdel-Naser MB, Kruger-Krasagakes S, Krasagakis K, Gollnick H, Abdel-Fattah A, Orfanos CE . Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo. Pigment Cell Res 1994; 7: 1\u20138.","journal-title":"Pigment Cell Res"},{"key":"BFgene201548_CR18","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.0902778","volume":"184","author":"RK Gregg","year":"2010","unstructured":"Gregg RK, Nichols L, Chen Y, Lu B, Engelhard VH . Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol 2010; 184: 1909\u20131917.","journal-title":"J Immunol"},{"key":"BFgene201548_CR19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris JE, Harris TH, Weninger W, Wherry EJ, Hunter CA, Turka LA . A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin. J Invest Dermatol 2012; 132: 1869\u20131876.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.autrev.2006.03.012","volume":"5","author":"K Oyarbide-Valencia","year":"2006","unstructured":"Oyarbide-Valencia K, van den Boorn JG, Denman CJ, Li M, Carlson JM, Hernandez C et al. Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev 2006; 5: 486\u2013492.","journal-title":"Autoimmun Rev"},{"key":"BFgene201548_CR21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.0022-202X.2004.23538.x","volume":"124","author":"J Steitz","year":"2005","unstructured":"Steitz J, Bruck J, Lenz J, Buchs S, Tuting T . Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo. J Invest Dermatol 2005; 124: 144\u2013150.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1087-0024.2004.00825.x","volume":"9","author":"IC Le Poole","year":"2004","unstructured":"Le Poole IC, Wankowicz-Kalinska A, van den Wijngaard RM, Nickoloff BJ, Das PK . Autoimmune aspects of depigmentation in vitiligo. J. Investig Dermatol Symp Proc 2004; 9: 68\u201372.","journal-title":"J. Investig Dermatol Symp Proc"},{"key":"BFgene201548_CR23","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","volume":"80","author":"R van den Wijngaard","year":"2000","unstructured":"van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P . Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000; 80: 1299\u20131309.","journal-title":"Lab Invest"},{"key":"BFgene201548_CR24","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","volume":"129","author":"JG van den Boorn","year":"2009","unstructured":"van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 2009; 129: 2220\u20132232.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","volume":"97","author":"R Harning","year":"1991","unstructured":"Harning R, Cui J, Bystryn JC . Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 1991; 97: 1078\u20131080.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/08916930108994127","volume":"34","author":"EH Kemp","year":"2001","unstructured":"Kemp EH, Waterman EA, Weetman AP . Autoimmune aspects of vitiligo. Autoimmunity 2001; 34: 65\u201377.","journal-title":"Autoimmunity"},{"key":"BFgene201548_CR27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","volume":"158","author":"GK Naughton","year":"1983","unstructured":"Naughton GK, Eisinger M, Bystryn JC . Antibodies to normal human melanocytes in vitiligo. J Exp Med 1983; 158: 246\u2013251.","journal-title":"J Exp Med"},{"key":"BFgene201548_CR28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/1523-1747.ep12522891","volume":"81","author":"GK Naughton","year":"1983","unstructured":"Naughton GK, Eisinger M, Bystryn JC . Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol 1983; 81: 540\u2013542.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","volume":"344","author":"YH Song","year":"1994","unstructured":"Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N . The role of tyrosinase in autoimmune vitiligo. Lancet 1994; 344: 1049\u20131052.","journal-title":"Lancet"},{"key":"BFgene201548_CR30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/exd.12659","volume":"24","author":"K Boniface","year":"2015","unstructured":"Boniface K, Rezvani HR, Seneschal J, Taieb A . Comment: The mystery of melanocyte demise in vitiligo. Exp Dermatol 2015; 24: 260\u2013261.","journal-title":"Exp Dermatol"},{"key":"BFgene201548_CR31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1468-3083.2012.04614.x","volume":"27","author":"M Arunachalam","year":"2013","unstructured":"Arunachalam M, Colucci R, Berti S, Kline JA, Lotti T, Lotti F et al. Autoimmune signals in non-segmental vitiligo patients are associated with distinct clinical parameters and toxic exposures. J Eur Acad Dermatol Venereol 2013; 27: 961\u2013966.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFgene201548_CR32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1523-1747.2003.12413.x","volume":"121","author":"RL Mandelcorn-Monson","year":"2003","unstructured":"Mandelcorn-Monson RL, Shear NH, Yau E, Sambhara S, Barber BH, Spaner D et al. Cytotoxic T lymphocyte reactivity to gp100, MelanA\/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients. J Invest Dermatol 2003; 121: 550\u2013556.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR33","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/bjd.13286","volume":"171","author":"R Colucci","year":"2014","unstructured":"Colucci R, Lotti F, Dragoni F, Arunachalam M, Lotti T, Benvenga S et al. High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol 2014; 171: 786\u2013798.","journal-title":"Br J Dermatol"},{"key":"BFgene201548_CR34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2340\/00015555-2080","volume":"95","author":"L Yang","year":"2015","unstructured":"Yang L, Wei Y, Sun Y, Shi W, Yang J, Zhu L et al. Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8+ cytotoxic T lymphocytes in vitiligo. Acta Derm Venereol 2015; 95: 664\u2013670.","journal-title":"Acta Derm Venereol"},{"key":"BFgene201548_CR35","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","volume":"6","author":"M Rashighi","year":"2014","unstructured":"Rashighi M, Agarwal P, Richmond JM, Harris TH, Dresser K, Su MW et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med 2014; 6: 223ra23.","journal-title":"Sci Transl Med"},{"key":"BFgene201548_CR36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2013.05.005","volume":"424","author":"MK Tembhre","year":"2013","unstructured":"Tembhre MK, Sharma VK, Sharma A, Chattopadhyay P, Gupta S . T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo. Clin Chim Acta 2013; 424: 27\u201332.","journal-title":"Clin Chim Acta"},{"key":"BFgene201548_CR37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12026-015-8632-6","volume":"62","author":"MK Tembhre","year":"2015","unstructured":"Tembhre MK, Parihar AS, Sharma A, Gupta S, Chattopadhyay P, Sharma VK . Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo. Immunol Res 2015; 62: 23\u201334.","journal-title":"Immunol Res"},{"key":"BFgene201548_CR38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2011.07.018","volume":"66","author":"R Khan","year":"2012","unstructured":"Khan R, Gupta S, Sharma A . Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-beta) in patients with vitiligo. J Am Acad Dermatol 2012; 66: 510\u2013511.","journal-title":"J Am Acad Dermatol"},{"key":"BFgene201548_CR39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","volume":"36","author":"DA Bassiouny","year":"2011","unstructured":"Bassiouny DA, Shaker O . Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol 2011; 36: 292\u2013297.","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"BFgene201548_CR40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/exd.12810","volume":"24","author":"Liliane Machado do Nascimento","year":"2015","unstructured":"Nascimento LM, Silva de Castro CC, Fava VM, Iani Werneck R, Mira MT . Genetic and biochemical evidence implicates the butyrylcholinesterase gene BCHE in vitiligo pathogenesis. Exp Dermatol 2015, e-pub ahead of print 17 July 2015; doi:10.1111\/exd.12810.","journal-title":"Experimental Dermatology"},{"key":"BFgene201548_CR41","first-page":"167","volume":"5","author":"HA Al-Shobaili","year":"2011","unstructured":"Al-Shobaili HA . Update on the genetics characterization of vitiligo. Int J Health Sci (Qassim) 2011; 5: 167\u2013179.","journal-title":"Int J Health Sci (Qassim)"},{"key":"BFgene201548_CR42","doi-asserted-by":"crossref","first-page":"e1000523","DOI":"10.1371\/journal.pgen.1000523","volume":"5","author":"Y Ren","year":"2009","unstructured":"Ren Y, Yang S, Xu S, Gao M, Huang W, Gao T et al. Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. PLoS Genet 2009; 5: e1000523.","journal-title":"PLoS Genet"},{"key":"BFgene201548_CR43","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","volume":"356","author":"Y Jin","year":"2007","unstructured":"Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007; 356: 1216\u20131225.","journal-title":"N Engl J Med"},{"key":"BFgene201548_CR44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ygeno.2014.06.003","volume":"104","author":"R Dey-Rao","year":"2014","unstructured":"Dey-Rao R, Smith JR, Chow S, Sinha AA . Differential gene expression analysis in CCLE lesions provides new insights regarding the genetics basis of skin vs systemic disease. Genomics 2014; 104: 144\u2013155.","journal-title":"Genomics"},{"key":"BFgene201548_CR45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygeno.2014.11.004","volume":"105","author":"R Dey-Rao","year":"2015","unstructured":"Dey-Rao R, Sinha AA . Genome-wide transcriptional profiling of chronic cutaneous lupus erythematosus (CCLE) peripheral blood identifies systemic alterations relevant to the skin manifestation. Genomics 2015; 105: 90\u2013100.","journal-title":"Genomics"},{"key":"BFgene201548_CR46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/gene.2013.44","volume":"14","author":"R Dey-Rao","year":"2013","unstructured":"Dey-Rao R, Seiffert-Sinha K, Sinha AA . Genome-wide expression analysis suggests unique disease-promoting and disease-preventing signatures in Pemphigus vulgaris. Genes Immun 2013; 14: 487\u2013499.","journal-title":"Genes Immun"},{"key":"BFgene201548_CR47","doi-asserted-by":"crossref","first-page":"e51040","DOI":"10.1371\/journal.pone.0051040","volume":"7","author":"R Yu","year":"2012","unstructured":"Yu R, Broady R, Huang Y, Wang Y, Yu J, Gao M et al. Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. PLoS One 2012; 7: e51040.","journal-title":"PLoS One"},{"key":"BFgene201548_CR48","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0167-7799(01)01790-5","volume":"19","author":"T Ito","year":"2001","unstructured":"Ito T, Chiba T, Yoshida M . Exploring the protein interactome using comprehensive two-hybrid projects. Trends Biotechnol 2001; 19: S23\u2013S27.","journal-title":"Trends Biotechnol"},{"key":"BFgene201548_CR49","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1093\/bioinformatics\/bti688","volume":"21","author":"S Wachi","year":"2005","unstructured":"Wachi S, Yoneda K, Wu R . Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 2005; 21: 4205\u20134208.","journal-title":"Bioinformatics"},{"key":"BFgene201548_CR50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0019-5154.135485","volume":"59","author":"Y Yang","year":"2014","unstructured":"Yang Y, Huang G, Yan X, Qing Z . Clinical analysis of thyroglobulin antibody and thyroid peroxidase antibody and their association with vitiligo. Indian J Dermatol 2014; 59: 357\u2013360.","journal-title":"Indian J Dermatol"},{"key":"BFgene201548_CR51","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4103\/2230-8210.122636","volume":"17","author":"FS Afsar","year":"2013","unstructured":"Afsar FS, Isleten F . Prevalence of thyroid function test abnormalities and thyroid autoantibodies in children with vitiligo. Indian J Endocrinol Metab 2013; 17: 1096\u20131099.","journal-title":"Indian J Endocrinol Metab"},{"key":"BFgene201548_CR52","first-page":"581657","volume":"2014","author":"A Khalil","year":"2014","unstructured":"Khalil A, Zaidman I, Bergman R, Elhasid R, Ben-Arush MW . Autoimmune complications after hematopoietic stem cell transplantation in children with nonmalignant disorders. ScientificWorldJournal 2014; 2014: 581657.","journal-title":"ScientificWorldJournal"},{"key":"BFgene201548_CR53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/1346-8138.12779","volume":"42","author":"YG Kim","year":"2015","unstructured":"Kim YG, Lee MW, Shin JM, Jeong MG, Ko JY . Colocalization of nonsegmental vitiligo and extragenital lichen sclerosus in a 45-year-old female patient with Hashimoto's thyroiditis. J Dermatol 2015; 42: 333\u20134.","journal-title":"J Dermatol"},{"key":"BFgene201548_CR54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fimmu.2013.00333","volume":"4","author":"Y Zhong","year":"2013","unstructured":"Zhong Y, Kinio A, Saleh M . Functions of NOD-like receptors in human diseases. Front Immunol 2013; 4: 333.","journal-title":"Front Immunol"},{"key":"BFgene201548_CR55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1523-1747.ep12312291","volume":"105","author":"SJ Orlow","year":"1995","unstructured":"Orlow SJ . Melanosomes are specialized members of the lysosomal lineage of organelles. J Invest Dermatol 1995; 105: 3\u20137.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1083\/jcb.200907122","volume":"187","author":"C Delevoye","year":"2009","unstructured":"Delevoye C, Hurbain I, Tenza D, Sibarita JB, Uzan-Gafsou S, Ohno H et al. AP-1 and KIF13A coordinate endosomal sorting and positioning during melanosome biogenesis. J Cell Biol 2009; 187: 247\u2013264.","journal-title":"J Cell Biol"},{"key":"BFgene201548_CR57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000357807","volume":"228","author":"V Ingordo","year":"2014","unstructured":"Ingordo V, Cazzaniga S, Raone B, Digiuseppe MD, Musumeci ML, Fai D et al. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study. Dermatology 2014; 228: 240\u2013249.","journal-title":"Dermatology"},{"key":"BFgene201548_CR58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2015\/631927","volume":"2015","author":"R Colucci","year":"2015","unstructured":"Colucci R, Dragoni F, Moretti S . Oxidative stress and immune system in vitiligo and thyroid diseases. Oxid Med Cell Longev 2015; 2015: 7 63192.","journal-title":"Oxid Med Cell Longev"},{"key":"BFgene201548_CR59","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/ajd.12321","volume":"56","author":"S Diaz-Angulo","year":"2015","unstructured":"Diaz-Angulo S, Lopez-Hoyos M, Munoz-Cacho P, Lopez-Escobar M, Gonzalez-Lopez MA . High prevalence of thyroid autoimmunity in patients with alopecia areata and vitiligo: a controlled study. Australas J Dermatol 2015; 56: 142\u2013143.","journal-title":"Australas J Dermatol"},{"key":"BFgene201548_CR60","doi-asserted-by":"crossref","unstructured":"Zhou H, Zhao J, Tang X, Zhang X, He D . Autoimmune hyperthyroidism, vitiligo, halo nevus and lupus. Am J Med Sci 2015, e-pub ahead of print 4 July 2015; doi:10.1097\/MAJ.0000000000000526.","DOI":"10.1097\/MAJ.0000000000000526"},{"key":"BFgene201548_CR61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/pcmr.12081","volume":"26","author":"Y Huang","year":"2013","unstructured":"Huang Y, Yi X, Jian Z, Wei C, Li S, Cai C et al. A single-nucleotide polymorphism of miR-196a-2 and vitiligo: an association study and functional analysis in a Han Chinese population. Pigment Cell Melanoma Res 2013; 26: 338\u2013347.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFgene201548_CR62","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-69361-1","volume-title":"Vitiligo","author":"M Picardo","year":"2010","unstructured":"Picardo M, Taieb A Vitiligo. Springer-Verlag: Heidelberg, 2010."},{"key":"BFgene201548_CR63","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","volume":"124","author":"TM Kroll","year":"2005","unstructured":"Kroll TM, Bommiasamy H, Boissy RE, Hernandez C, Nickoloff BJ, Mestril R et al. 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. J Invest Dermatol 2005; 124: 798\u2013806.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jcph.371","volume":"55","author":"AL Shroads","year":"2015","unstructured":"Shroads AL, Coats BS, McDonough CW, Langaee T, Stacpoole PW . Haplotype variations in glutathione transferase zeta 1 influence the kinetics and dynamics of chronic dichloroacetate in children. J Clin Pharmacol 2015; 55: 50\u201355.","journal-title":"J Clin Pharmacol"},{"key":"BFgene201548_CR65","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/exd.12621","volume":"24","author":"S Wang","year":"2015","unstructured":"Wang S, Liu D, Ning W, Xu A . Cytosolic dsDNA triggers apoptosis and pro-inflammatory cytokine production in normal human melanocytes. Exp Dermatol 2015; 24: 298\u2013300.","journal-title":"Exp Dermatol"},{"key":"BFgene201548_CR66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5021\/ad.2012.24.2.115","volume":"24","author":"AY Lee","year":"2012","unstructured":"Lee AY . Role of keratinocytes in the development of vitiligo. Ann Dermatol 2012; 24: 115\u2013125.","journal-title":"Ann Dermatol"},{"key":"BFgene201548_CR67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0625.2010.01208.x","volume":"20","author":"N Yu","year":"2011","unstructured":"Yu N, Zhang S, Sun T, Kang K, Guan M, Xiang L . Double-stranded RNA induces melanocyte death via activation of Toll-like receptor 3. Exp Dermatol 2011; 20: 134\u2013139.","journal-title":"Exp Dermatol"},{"key":"BFgene201548_CR68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ygeno.2011.08.009","volume":"98","author":"AB Coda","year":"2011","unstructured":"Coda AB, Sinha AA . Integration of genome-wide transcriptional and genetic profiles provides insights into disease development and clinical heterogeneity in alopecia areata. Genomics 2011; 98: 431\u2013439.","journal-title":"Genomics"},{"key":"BFgene201548_CR69","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.2353\/ajpath.2006.050769","volume":"169","author":"P Manga","year":"2006","unstructured":"Manga P, Sheyn D, Yang F, Sarangarajan R, Boissy RE . A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: implications for vitiligo. Am J Pathol 2006; 169: 1652\u20131662.","journal-title":"Am J Pathol"},{"key":"BFgene201548_CR70","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","volume":"44","author":"Y Jin","year":"2012","unstructured":"Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet 2012; 44: 676\u2013680.","journal-title":"Nat Genet"},{"key":"BFgene201548_CR71","first-page":"2107","volume":"29","author":"JP Chen","year":"2009","unstructured":"Chen JP, Li HP, Jin SH, Zhang JT, Li J . [Detection of serum autoantibodies to melanocyte and correlation between melanoma antigen recognized by T-cells and vitiligo in children]. Nan Fang Yi Ke Da Xue Xue Bao 2009; 29: 2107\u20132108, 2111.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"BFgene201548_CR72","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/jid.2010.34","volume":"130","author":"CC Silva de Castro","year":"2010","unstructured":"Silva de Castro CC, do Nascimento LM, Walker G, Werneck RI, Nogoceke E, Mira MT . Genetic variants of the DDR1 gene are associated with vitiligo in two independent Brazilian population samples. J Invest Dermatol 2010; 130: 1813\u20131818.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR73","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2004.01.082","volume":"315","author":"KU Schallreuter","year":"2004","unstructured":"Schallreuter KU, Elwary SM, Gibbons NC, Rokos H, Wood JM . Activation\/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 2004; 315: 502\u2013508.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgene201548_CR74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0923-1811(02)00151-2","volume":"31","author":"CX Tu","year":"2003","unstructured":"Tu CX, Gu JS, Lin XR . Increased interleukin-6 and granulocyte-macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo. J Dermatol Sci 2003; 31: 73\u201378.","journal-title":"J Dermatol Sci"},{"key":"BFgene201548_CR75","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1210\/en.2007-1317","volume":"149","author":"JD Spencer","year":"2008","unstructured":"Spencer JD, Gibbons NC, Bohm M, Schallreuter KU . The Ca2+-binding capacity of epidermal furin is disrupted by H2O2-mediated oxidation in vitiligo. Endocrinology 2008; 149: 1638\u20131645.","journal-title":"Endocrinology"},{"key":"BFgene201548_CR76","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1034\/j.1600-0749.2003.00062.x","volume":"16","author":"GY Na","year":"2003","unstructured":"Na GY, Lee KH, Kim MK, Lee SJ, Kim DW, Kim JC . Polymorphisms in the melanocortin-1 receptor (MC1R) and agouti signaling protein (ASIP) genes in Korean vitiligo patients. Pigment Cell Res 2003; 16: 383\u2013387.","journal-title":"Pigment Cell Res"},{"key":"BFgene201548_CR77","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1523-1747.2003.12494.x","volume":"121","author":"RV Gottumukkala","year":"2003","unstructured":"Gottumukkala RV, Waterman EA, Herd LM, Gawkrodger DJ, Watson PF, Weetman AP et al. Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor. J Invest Dermatol 2003; 121: 765\u2013770.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR78","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.jid.5700538","volume":"127","author":"JD Spencer","year":"2007","unstructured":"Spencer JD, Gibbons NC, Rokos H, Peters EM, Wood JM, Schallreuter KU . Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo. J Invest Dermatol 2007; 127: 411\u2013420.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR79","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1468-3083.2006.01686.x","volume":"20","author":"Q Xia","year":"2006","unstructured":"Xia Q, Zhou WM, Liang YH, Ge HS, Liu HS, Wang JY et al. MHC haplotypic association in Chinese Han patients with vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 941\u2013946.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFgene201548_CR80","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.gene.6364016","volume":"4","author":"CB Casp","year":"2003","unstructured":"Casp CB, She JX, McCormack WT . Genes of the LMP\/TAP cluster are associated with the human autoimmune disease vitiligo. Genes Immun 2003; 4: 492\u2013499.","journal-title":"Genes Immun"},{"key":"BFgene201548_CR81","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1038\/jid.2008.161","volume":"128","author":"M Li","year":"2008","unstructured":"Li M, Sun D, Li C, Zhang Z, Gao L, Li K et al. Functional polymorphisms of the FAS gene associated with risk of vitiligo in Chinese populations: a case-control analysis. J Invest Dermatol 2008; 128: 2820\u20132824.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/ced.12446","volume":"40","author":"IE Aydingoz","year":"2015","unstructured":"Aydingoz IE, Kanmaz-Ozer M, Gedikbasi A, Vural P, Dogru-Abbasoglu S, Uysal M . The combination of tumour necrosis factor-alpha -308\u2009A and interleukin-10 -1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo. Clin Exp Dermatol 2015; 40: 71\u201377.","journal-title":"Clin Exp Dermatol"},{"key":"BFgene201548_CR83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1155\/2008\/210609","volume":"24","author":"A Abanmi","year":"2008","unstructured":"Abanmi A, Al Harthi F, Zouman A, Kudwah A, Jamal MA, Arfin M et al. Association of interleukin-10 gene promoter polymorphisms in Saudi patients with vitiligo. Dis Markers 2008; 24: 51\u201357.","journal-title":"Dis Markers"},{"key":"BFgene201548_CR84","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00403-006-0699-4","volume":"298","author":"A Abanmi","year":"2006","unstructured":"Abanmi A, Al Harthi F, Al Baqami R, Al Assaf S, Zouman A, Arfin M et al. Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Arch Dermatol Res 2006; 298: 347\u2013352.","journal-title":"Arch Dermatol Res"},{"key":"BFgene201548_CR85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00403-002-0295-1","volume":"294","author":"U Tursen","year":"2002","unstructured":"Tursen U, Kaya TI, Erdal ME, Derici E, Gunduz O, Ikizoglu G . Association between catechol-O-methyltransferase polymorphism and vitiligo. Arch Dermatol Res 2002; 294: 143\u2013146.","journal-title":"Arch Dermatol Res"},{"key":"BFgene201548_CR86","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.jid.5701100","volume":"128","author":"KU Schallreuter","year":"2008","unstructured":"Schallreuter KU, Rubsam K, Gibbons NC, Maitland DJ, Chavan B, Zothner C et al. Methionine sulfoxide reductases A and B are deactivated by hydrogen peroxide (H2O2) in the epidermis of patients with vitiligo. J Invest Dermatol 2008; 128: 808\u2013815.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR87","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/381134","volume":"74","author":"RA Spritz","year":"2004","unstructured":"Spritz RA, Gowan K, Bennett DC, Fain PR . Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 2004; 74: 188\u2013191.","journal-title":"Am J Hum Genet"},{"key":"BFgene201548_CR88","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1755-148X.2008.00462.x","volume":"21","author":"M Dwivedi","year":"2008","unstructured":"Dwivedi M, Laddha NC, Shajil EM, Shah BJ, Begum R . The ACE gene I\/D polymorphism is not associated with generalized vitiligo susceptibility in Gujarat population. Pigment Cell Melanoma Res 2008; 21: 407\u2013408.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFgene201548_CR89","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1470320313478285","volume":"16","author":"GG Song","year":"2013","unstructured":"Song GG, Bae SC, Kim JH, Lee YH . The angiotensin-converting enzyme insertion\/deletion polymorphism and susceptibility to rheumatoid arthritis, vitiligo and psoriasis: a meta-analysis. J Renin-Angiotensin-Aldosterone Syst 2013; 16: 195\u2013202.","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"BFgene201548_CR90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00403-008-0904-8","volume":"301","author":"AM Namian","year":"2009","unstructured":"Namian AM, Shahbaz S, Salmanpoor R, Namazi MR, Dehghani F, Kamali-Sarvestani E . Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients. Arch Dermatol Res 2009; 301: 21\u201325.","journal-title":"Arch Dermatol Res"},{"key":"BFgene201548_CR91","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0749.2007.00406.x","volume":"20","author":"S Em","year":"2007","unstructured":"Em S, Laddha NC, Chatterjee S, Gani AR, Malek RA, Shah BJ et al. Association of catalase T\/C exon 9 and glutathione peroxidase codon 200 polymorphisms in relation to their activities and oxidative stress with vitiligo susceptibility in Gujarat population. Pigment Cell Res 2007; 20: 405\u2013407.","journal-title":"Pigment Cell Res"},{"key":"BFgene201548_CR92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1155\/2012\/540597","volume":"33","author":"A Yasar","year":"2012","unstructured":"Yasar A, Gunduz K, Onur E, Calkan M . Serum homocysteine, vitamin B12, folic acid levels and methylenetetrahydrofolate reductase (MTHFR) gene polymorphism in vitiligo. Dis Markers 2012; 33: 85\u201389.","journal-title":"Dis Markers"},{"key":"BFgene201548_CR93","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.lfs.2007.05.006","volume":"81","author":"YK Uhm","year":"2007","unstructured":"Uhm YK, Yoon SH, Kang IJ, Chung JH, Yim SV, Lee MH . Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population. Life Sci 2007; 81: 223\u2013227.","journal-title":"Life Sci"},{"key":"BFgene201548_CR94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0749.2004.00196.x","volume":"18","author":"A Blomhoff","year":"2005","unstructured":"Blomhoff A, Kemp EH, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE et al. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Res 2005; 18: 55\u201358.","journal-title":"Pigment Cell Res"},{"key":"BFgene201548_CR95","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fitote.2014.08.007","volume":"99C","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Wang S, Lin F, Li Q, Xu A . The therapeutic effects of EGCG on vitiligo. Fitoterapia 2014; 99C: 243\u2013251.","journal-title":"Fitoterapia"},{"key":"BFgene201548_CR96","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/exd.12183","volume":"22","author":"JA Mosenson","year":"2013","unstructured":"Mosenson JA, Eby JM, Hernandez C, Le Poole IC . A central role for inducible heat-shock protein 70 in autoimmune vitiligo. Exp Dermatol 2013; 22: 566\u2013569.","journal-title":"Exp Dermatol"},{"key":"BFgene201548_CR97","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bjd.12467","volume":"169","author":"M Dwivedi","year":"2013","unstructured":"Dwivedi M, Laddha NC, Mansuri MS, Marfatia YS, Begum R . Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population. Br J Dermatol 2013; 169: 1114\u20131125.","journal-title":"Br J Dermatol"},{"key":"BFgene201548_CR98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0749.2007.00384.x","volume":"20","author":"RA Spritz","year":"2007","unstructured":"Spritz RA . The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 2007; 20: 271\u2013278.","journal-title":"Pigment Cell Res"},{"key":"BFgene201548_CR99","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000131501","volume":"10","author":"RA Spritz","year":"2008","unstructured":"Spritz RA . The genetics of generalized vitiligo. Curr Dir Autoimmun 2008; 10: 244\u2013257.","journal-title":"Curr Dir Autoimmun"},{"key":"BFgene201548_CR100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1346-8138.12147","volume":"40","author":"RA Spritz","year":"2013","unstructured":"Spritz RA . Modern vitiligo genetics sheds new light on an ancient disease. J Dermatol 2013; 40: 310\u2013318.","journal-title":"J Dermatol"},{"key":"BFgene201548_CR101","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jdermsci.2007.06.004","volume":"48","author":"K Kingo","year":"2007","unstructured":"Kingo K, Aunin E, Karelson M, Philips MA, Ratsep R, Silm H et al. Gene expression analysis of melanocortin system in vitiligo. J Dermatol Sci 2007; 48: 113\u2013122.","journal-title":"J Dermatol Sci"},{"key":"BFgene201548_CR102","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00251-015-0843-4","volume":"67","author":"S Li","year":"2015","unstructured":"Li S, Yao W, Pan Q, Tang X, Zhao S, Wang W et al. Association analysis revealed one susceptibility locus for vitiligo with immune-related diseases in the Chinese Han population. Immunogenetics 2015; 67: 347\u2013354.","journal-title":"Immunogenetics"},{"key":"BFgene201548_CR103","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/jid.2012.320","volume":"133","author":"XF Tang","year":"2013","unstructured":"Tang XF, Zhang Z, Hu DY, Xu AE, Zhou HS, Sun LD et al. Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population. J Invest Dermatol 2013; 133: 403\u2013410.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR104","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ajmg.a.32210","volume":"146A","author":"N Rahner","year":"2008","unstructured":"Rahner N, Hoefler G, Hogenauer C, Lackner C, Steinke V, Sengteller M et al. Compound heterozygosity for two MSH6 mutations in a patient with early onset colorectal cancer, vitiligo and systemic lupus erythematosus. Am J Med Genet A 2008; 146A: 1314\u20131319.","journal-title":"Am J Med Genet A"},{"key":"BFgene201548_CR105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/ijd.1978.17.9.755","volume":"17","author":"BK Nair","year":"1978","unstructured":"Nair BK . Vitiligo\u2014a retrospect. Int J Dermatol 1978; 17: 755\u2013757.","journal-title":"Int J Dermatol"},{"key":"BFgene201548_CR106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","volume":"14","author":"M Dwivedi","year":"2015","unstructured":"Dwivedi M, Helen Kemp E, Laddha NC, Mansuri MS, Weetman AP, Begum R . Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics. Autoimmun Rev 2015; 14: 49\u201356.","journal-title":"Autoimmun Rev"},{"key":"BFgene201548_CR107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","volume":"223","author":"WP Arend","year":"2008","unstructured":"Arend WP, Palmer G, Gabay C . IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008; 223: 20\u201338.","journal-title":"Immunol Rev"},{"key":"BFgene201548_CR108","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479\u2013490.","journal-title":"Immunity"},{"key":"BFgene201548_CR109","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cyto.2007.09.013","volume":"40","author":"D Moulin","year":"2007","unstructured":"Moulin D, Donze O, Talabot-Ayer D, Mezin F, Palmer G, Gabay C . Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 2007; 40: 216\u2013225.","journal-title":"Cytokine"},{"key":"BFgene201548_CR110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/ced.12464","volume":"40","author":"P Li","year":"2015","unstructured":"Li P, Ma H, Han D, Mou K . Interleukin-33 affects cytokine production by keratinocytes in vitiligo. Clin Exp Dermatol 2015; 40: 163\u2013170.","journal-title":"Clin Exp Dermatol"},{"key":"BFgene201548_CR111","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archderm.138.2.273","volume":"138","author":"S Moretti","year":"2002","unstructured":"Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabbri P . Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines. Arch Dermatol 2002; 138: 273\u2013274.","journal-title":"Arch Dermatol"},{"key":"BFgene201548_CR112","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1073\/pnas.1222808110","volume":"110","author":"CB Levandowski","year":"2013","unstructured":"Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, Jin Y et al. NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1beta processing via the NLRP1 inflammasome. Proc Natl Acad Sci USA 2013; 110: 2952\u20132956.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene201548_CR113","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2009.01.006","volume":"21","author":"JH Pedra","year":"2009","unstructured":"Pedra JH, Cassel SL, Sutterwala FS . Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol 2009; 21: 10\u201316.","journal-title":"Curr Opin Immunol"},{"key":"BFgene201548_CR114","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J . The inflammasomes. Cell 2010; 140: 821\u2013832.","journal-title":"Cell"},{"key":"BFgene201548_CR115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.05.001","volume":"61","author":"CA Yang","year":"2015","unstructured":"Yang CA, Chiang BL . Inflammasomes and human autoimmunity: a comprehensive review. J Autoimmun 2015; 61: 1\u20138.","journal-title":"J Autoimmun"},{"key":"BFgene201548_CR116","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.3103","volume":"16","author":"CA Nold-Petry","year":"2015","unstructured":"Nold-Petry CA, Lo CY, Rudloff I, Elgass KD, Li S, Gantier MP et al. IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat Immunol 2015; 16: 354\u2013365.","journal-title":"Nat Immunol"},{"key":"BFgene201548_CR117","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00403-011-1154-8","volume":"303","author":"CX Tu","year":"2011","unstructured":"Tu CX, Jin WW, Lin M, Wang ZH, Man MQ . Levels of TGF-beta(1) in serum and culture supernatants of CD4(+)CD25 (+) T cells from patients with non-segmental vitiligo. Arch Dermatol Res 2011; 303: 685\u2013689.","journal-title":"Arch Dermatol Res"},{"key":"BFgene201548_CR118","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/pcmr.12355","volume":"28","author":"L Zhou","year":"2015","unstructured":"Zhou L, Shi YL, Li K, Hamzavi I, Gao TW, Huggins RH et al. Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development. Pigment Cell Melanoma Res 2015; 28: 324\u2013329.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFgene201548_CR119","doi-asserted-by":"crossref","first-page":"e18907","DOI":"10.1371\/journal.pone.0018907","volume":"6","author":"CQ Wang","year":"2011","unstructured":"Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J, Moussai D, Gulati N, Sullivan-Whalen M et al. Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS One 2011; 6: e18907.","journal-title":"PLoS One"},{"key":"BFgene201548_CR120","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/jid.2011.413","volume":"132","author":"H Ando","year":"2012","unstructured":"Ando H, Niki Y, Ito M, Akiyama K, Matsui MS, Yarosh DB et al. Melanosomes are transferred from melanocytes to keratinocytes through the processes of packaging, release, uptake, and dispersion. J Invest Dermatol 2012; 132: 1222\u20131229.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR121","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrm2728","volume":"10","author":"H Stenmark","year":"2009","unstructured":"Stenmark H . Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 2009; 10: 513\u2013525.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFgene201548_CR122","doi-asserted-by":"crossref","first-page":"21751","DOI":"10.1074\/jbc.M113.541177","volume":"289","author":"H Chung","year":"2014","unstructured":"Chung H, Jung H, Lee JH, Oh HY, Kim OB, Han IO et al. Keratinocyte-derived laminin-332 protein promotes melanin synthesis via regulation of tyrosine uptake. J Biol Chem 2014; 289: 21751\u201321759.","journal-title":"J Biol Chem"},{"key":"BFgene201548_CR123","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1083\/jcb.142.3.827","volume":"142","author":"C Bertolotto","year":"1998","unstructured":"Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP et al. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 1998; 142: 827\u2013835.","journal-title":"J Cell Biol"},{"key":"BFgene201548_CR124","first-page":"33","volume":"66","author":"M Otreba","year":"2012","unstructured":"Otreba M, Rok J, Buszman E, Wrzesniok D . [Regulation of melanogenesis: the role of cAMP and MITF]. Postepy Hig Med Dosw (Online) 2012; 66: 33\u201340.","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"BFgene201548_CR125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jdermsci.2008.03.013","volume":"52","author":"K Kingo","year":"2008","unstructured":"Kingo K, Aunin E, Karelson M, Ratsep R, Silm H, Vasar E et al. Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo. J Dermatol Sci 2008; 52: 39\u201346.","journal-title":"J Dermatol Sci"},{"key":"BFgene201548_CR126","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","volume":"84","author":"A Slominski","year":"2004","unstructured":"Slominski A, Tobin DJ, Shibahara S, Wortsman J . Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004; 84: 1155\u20131228.","journal-title":"Physiol Rev"},{"key":"BFgene201548_CR127","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1523-1747.ep12480997","volume":"97","author":"J Cui","year":"1991","unstructured":"Cui J, Shen LY, Wang GC . Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991; 97: 410\u2013416.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR128","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/jid.2013.235","volume":"133","author":"T Yamada","year":"2013","unstructured":"Yamada T, Hasegawa S, Inoue Y, Date Y, Yamamoto N, Mizutani H et al. Wnt\/beta-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation. J Invest Dermatol 2013; 133: 2753\u20132762.","journal-title":"J Invest Dermatol"},{"issue":"12","key":"BFgene201548_CR129","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/jid.2015.335","volume":"135","author":"Claire Regazzetti","year":"2015","unstructured":"Regazzetti C, Joly F, Marty C, Rivier M, Mehul B, Reiniche P et al. Transcriptional analysis of vitiligo skins reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients. J Invest Dermatol 2015, e-pub ahead of print 31 August 2015; doi:10.1038\/jid.2015.335.","journal-title":"Journal of Investigative Dermatology"},{"issue":"7","key":"BFgene201548_CR130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/gene.2010.32","volume":"11","author":"AB Coda","year":"2010","unstructured":"Coda AB, Qafalijaj Hysa V, Seiffert-Sinha K, Sinha AA . Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity. Genes Immun 2010; 11 (7): 531\u2013541.","journal-title":"Genes Immun"},{"key":"BFgene201548_CR131","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cup.12437","volume":"42","author":"A Walker","year":"2015","unstructured":"Walker A, Mesinkovska NA, Boncher J, Tamburro J, Bergfeld WF . Colocalization of vitiligo and alopecia areata presenting as poliosis. J Cutan Pathol 2015; 42: 150\u2013154.","journal-title":"J Cutan Pathol"},{"key":"BFgene201548_CR132","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamadermatol.2014.3324","volume":"151","author":"GC Mohan","year":"2015","unstructured":"Mohan GC, Silverberg JI . Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis. JAMA Dermatol 2015; 151: 522\u2013528.","journal-title":"JAMA Dermatol"},{"key":"BFgene201548_CR133","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/jdv.12870","volume":"29","author":"YT Chen","year":"2014","unstructured":"Chen YT, Chen YJ, Hwang CY, Lin MW, Chen TJ, Chen CC et al. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol 2014; 29: 1362\u20131369.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFgene201548_CR134","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2741\/1831","volume":"11","author":"L Larue","year":"2006","unstructured":"Larue L, Delmas V . The WNT\/Beta-catenin pathway in melanoma. Front Biosci 2006; 11: 733\u2013742.","journal-title":"Front Biosci"},{"issue":"2","key":"BFgene201548_CR135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1755-148X.2010.00800.x","volume":"24","author":"B Bellei","year":"2011","unstructured":"Bellei B, Pitisci A, Catricala C, Larue L, Picardo M . Wnt\/beta-catenin signaling is stimulated by alpha-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation. Pigment Cell Melanoma Res 2011; 24 (2): 309\u2013325.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFgene201548_CR136","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","volume":"12","author":"C Levy","year":"2006","unstructured":"Levy C, Khaled M, Fisher DE . MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 2006; 12: 406\u2013414.","journal-title":"Trends Mol Med"},{"key":"BFgene201548_CR137","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1755-148X.2011.00871.x","volume":"24","author":"OM Eichhoff","year":"2011","unstructured":"Eichhoff OM, Weeraratna A, Zipser MC, Denat L, Widmer DS, Xu M et al. Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. Pigment Cell Melanoma Res 2011; 24: 631\u2013642.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFgene201548_CR138","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0749.2003.00070.x","volume":"16","author":"Y Gauthier","year":"2003","unstructured":"Gauthier Y, Cario Andre M, Taieb A . A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003; 16: 322\u2013332.","journal-title":"Pigment Cell Res"},{"key":"BFgene201548_CR139","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00128071-200203050-00001","volume":"3","author":"CL Huang","year":"2002","unstructured":"Huang CL, Nordlund JJ, Boissy R . Vitiligo: a manifestation of apoptosis? Am J Clin Dermatol 2002; 3: 301\u2013308.","journal-title":"Am J Clin Dermatol"},{"key":"BFgene201548_CR140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.cellbio.16.1.653","volume":"16","author":"C Grandori","year":"2000","unstructured":"Grandori C, Cowley SM, James LP, Eisenman RN . The Myc\/Max\/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000; 16: 653\u2013699.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFgene201548_CR141","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3748\/wjg.v21.i7.2011","volume":"21","author":"RN Aravalli","year":"2015","unstructured":"Aravalli RN, Talbot NC, Steer CJ . Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing. World J Gastroenterol 2015; 21: 2011\u20132029.","journal-title":"World J Gastroenterol"},{"key":"BFgene201548_CR142","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/emboj\/19.2.263","volume":"19","author":"CV Ramana","year":"2000","unstructured":"Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BR et al. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J 2000; 19: 263\u2013272.","journal-title":"EMBO J"},{"key":"BFgene201548_CR143","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/asheducation-2014.1.100","volume":"2014","author":"G Ott","year":"2014","unstructured":"Ott G . Impact of MYC on malignant behavior. Hematology Am Soc Hematol Educ Program 2014; 2014: 100\u2013106.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"BFgene201548_CR144","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.3748\/wjg.14.7199","volume":"14","author":"GY Liu","year":"2008","unstructured":"Liu GY, Luo Q, Xiong B, Pan C, Yin P, Liao HF et al. Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors. World J Gastroenterol 2008; 14: 7199\u20137207.","journal-title":"World J Gastroenterol"},{"key":"BFgene201548_CR145","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1081\/CNV-120005904","volume":"20","author":"J Utikal","year":"2002","unstructured":"Utikal J, Leiter U, Udart M, Kaskel P, Peter RU, Krahn GM . Expression of c-myc and bcl-2 in primary and advanced cutaneous melanoma. Cancer Invest 2002; 20: 914\u2013921.","journal-title":"Cancer Invest"},{"key":"BFgene201548_CR146","first-page":"3647","volume":"28","author":"S Shishodia","year":"2008","unstructured":"Shishodia S, Harikumar KB, Dass S, Ramawat KG, Aggarwal BB . The guggul for chronic diseases: ancient medicine, modern targets. Anticancer Res 2008; 28: 3647\u20133664.","journal-title":"Anticancer Res"},{"key":"BFgene201548_CR147","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV . MYC on the path to cancer. Cell 2012; 149: 22\u201335.","journal-title":"Cell"},{"key":"BFgene201548_CR148","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40169-015-0054-5","volume":"4","author":"WR Swindell","year":"2015","unstructured":"Swindell WR, Sarkar MK, Stuart PE, Voorhees JJ, Elder JT, Johnston A et al. Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sites. Clin Transl Med 2015; 4: 13.","journal-title":"Clin Transl Med"},{"key":"BFgene201548_CR149","first-page":"2637","volume":"8","author":"F Loganzo Jr","year":"1993","unstructured":"Loganzo F Jr, Dosik JS, Zhao Y, Vidal MJ, Nanus DM, Sudol M et al. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma. Oncogene 1993; 8: 2637\u20132644.","journal-title":"Oncogene"},{"key":"BFgene201548_CR150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/scbi.1995.0028","volume":"6","author":"DL Brautigan","year":"1995","unstructured":"Brautigan DL . Flicking the switches: phosphorylation of serine\/threonine protein phosphatases. Semin Cancer Biol 1995; 6: 211\u2013217.","journal-title":"Semin Cancer Biol"},{"key":"BFgene201548_CR151","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00008390-200112000-00004","volume":"11","author":"M Deichmann","year":"2001","unstructured":"Deichmann M, Polychronidis M, Wacker J, Thome M, Naher H . The protein phosphatase 2\u2009A subunit Bgamma gene is identified to be differentially expressed in malignant melanomas by subtractive suppression hybridization. Melanoma Res 2001; 11: 577\u2013585.","journal-title":"Melanoma Res"},{"key":"BFgene201548_CR152","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1101\/gad.854200","volume":"14","author":"C Petritsch","year":"2000","unstructured":"Petritsch C, Beug H, Balmain A, Oft M . TGF-beta inhibits p70 S6 kinase via protein phosphatase 2\u2009A to induce G(1) arrest. Genes Dev 2000; 14: 3093\u20133101.","journal-title":"Genes Dev"},{"key":"BFgene201548_CR153","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH659>3.0.CO;2-D","volume":"191","author":"DJ Tobin","year":"2000","unstructured":"Tobin DJ, Swanson NN, Pittelkow MR, Peters EM, Schallreuter KU . Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol 2000; 191: 407\u2013416.","journal-title":"J Pathol"},{"key":"BFgene201548_CR154","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0749.2004.00198.x","volume":"18","author":"T Hirobe","year":"2005","unstructured":"Hirobe T . Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res 2005; 18: 2\u201312.","journal-title":"Pigment Cell Res"},{"key":"BFgene201548_CR155","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1242\/dev.121.5.1547","volume":"121","author":"EV Sviderskaya","year":"1995","unstructured":"Sviderskaya EV, Wakeling WF, Bennett DC . A cloned, immortal line of murine melanoblasts inducible to differentiate to melanocytes. Development 1995; 121: 1547\u20131557.","journal-title":"Development"},{"key":"BFgene201548_CR156","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","volume":"25","author":"JM Richmond","year":"2013","unstructured":"Richmond JM, Frisoli ML, Harris JE . Innate immune mechanisms in vitiligo: danger from within. Curr Opin Immunol 2013; 25: 676\u2013682.","journal-title":"Curr Opin Immunol"},{"key":"BFgene201548_CR157","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1186\/gb-2008-9-12-r170","volume":"9","author":"R Chen","year":"2008","unstructured":"Chen R, Morgan AA, Dudley J, Deshpande T, Li L, Kodama K et al. FitSNPs: highly differentially expressed genes are more likely to have variants associated with disease. Genome Biol 2008; 9: R170.","journal-title":"Genome Biol"},{"key":"BFgene201548_CR158","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1365-2249.2002.01949.x","volume":"129","author":"EA Waterman","year":"2002","unstructured":"Waterman EA, Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP . Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA\/MART1. Clin Exp Immunol 2002; 129: 527\u2013532.","journal-title":"Clin Exp Immunol"},{"key":"BFgene201548_CR159","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/pcmr.12356","volume":"28","author":"Y Jin","year":"2015","unstructured":"Jin Y, Hayashi M, Fain PR, Suzuki T, Fukai K, Oiso N et al. Major association of vitiligo with HLA-A*02:01 in Japanese. Pigment Cell Melanoma Res 2015; 28: 360\u2013362.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFgene201548_CR160","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/jid.2014.529","volume":"135","author":"P Agarwal","year":"2015","unstructured":"Agarwal P, Rashighi M, Essien KI, Richmond JM, Randall L, Pazoki-Toroudi H et al. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol 2015; 135: 1080\u20131088.","journal-title":"J Invest Dermatol"},{"key":"BFgene201548_CR161","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nbt0604-656b","volume":"22","author":"Z Wu","year":"2004","unstructured":"Wu Z, Irizarry RA . Preprocessing of oligonucleotide array data. Nat Biotechnol 2004; 22: 656\u2013658; author reply 658.","journal-title":"Nat Biotechnol"},{"key":"BFgene201548_CR162","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"Huang","year":"2009","unstructured":"Huang, da W, Sherman BT, Lempicki RA . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44\u201357.","journal-title":"Nat Protoc"},{"key":"BFgene201548_CR163","doi-asserted-by":"crossref","first-page":"W169","DOI":"10.1093\/nar\/gkm415","volume":"35","author":"Huang","year":"2007","unstructured":"Huang,, Sherman BT, Tan Q, Kir J, Liu D, Bryant D et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007; 35: W169\u2013W175.","journal-title":"Nucleic Acids Res"},{"key":"BFgene201548_CR164","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/bioinformatics\/btl633","volume":"23","author":"I Rivals","year":"2007","unstructured":"Rivals I, Personnaz L, Taing L, Potier MC . Enrichment or depletion of a GO category within a class of genes: which test? Bioinformatics 2007; 23: 401\u2013407.","journal-title":"Bioinformatics"},{"key":"BFgene201548_CR165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1745-6150-6-15","volume":"6","author":"E Shmelkov","year":"2011","unstructured":"Shmelkov E, Tang Z, Aifantis I, Statnikov A . Assessing quality and completeness of human transcriptional regulatory pathways on a genome-wide scale. Biol Direct 2011; 6: 15.","journal-title":"Biol Direct"},{"key":"BFgene201548_CR166","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/1471-2105-13-S16-S13","volume":"13","author":"M Bessarabova","year":"2012","unstructured":"Bessarabova M, Ishkin A, JeBailey L, Nikolskaya T, Nikolsky Y . Knowledge-based analysis of proteomics data. BMC Bioinformatics 2012; 13: S13.","journal-title":"BMC Bioinformatics"},{"key":"BFgene201548_CR167","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1093\/bioinformatics\/18.suppl_1.S233","volume":"18","author":"T Ideker","year":"2002","unstructured":"Ideker T, Ozier O, Schwikowski B, Siegel AF . Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 2002; 18: S233\u2013S240.","journal-title":"Bioinformatics"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gene201548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201548","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T11:57:02Z","timestamp":1718193422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gene201548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,12]]},"references-count":167,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["BFgene201548"],"URL":"https:\/\/doi.org\/10.1038\/gene.2015.48","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,12]]},"assertion":[{"value":"18 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}